HeartFlow launches new FFR-CT version

Cardiovascular software developer HeartFlow has launched the newest generation of its software for calculating fractional flow reserve (FFR) from CT scans.

The new version of the company's HeartFlow Analysis FFR-CT software includes major advancements in the processes and algorithms used to calculate FFR-CT values. The application has been cleared by the U.S. Food and Drug Administration (FDA).

New enhancements to the software include the following:

  • Advanced algorithms and faster case processing that enable HeartFlow Analysis to get results to clinicians more quickly
  • A cloud-based infrastructure that uses the Amazon Web Services (AWS) platform, which ensures more secure, robust, and scalable delivery of HeartFlow results
  • Heightened security measures

HeartFlow Analysis provides noninvasive measures of the extent of coronary artery disease. The first version of the software was cleared by the FDA in 2014.

Page 1 of 156
Next Page